JAMES W. FRESTON, M.D.
This content is PDF only. Please click on the PDF icon to access.
Cimetidine already is used extensively in the United States and abroad. This histamine H2-receptor antagonist was approved by the Food and Drug Administration (FDA) in August 1977 for the treatment of duodenal ulcer disease, the Zollinger-Ellison syndrome, and other hypersecretory conditions. Despite the few approved indications, approximately 2 million patients in the United States had received the drug by October 1978. There are more approved indications in the United Kingdom, a circumstance that may help explain the remarkably heavy use in that country: Approximately 1% of the British population received the drug within 10 months of its release.
It is axiomatic that
FRESTON JW. Cimetidine and Granulocytopenia. Ann Intern Med. 1979;90:264–265. doi: https://doi.org/10.7326/0003-4819-90-2-264
Download citation file:
Published: Ann Intern Med. 1979;90(2):264-265.
Results provided by:
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use